Poly(εepsilon;-caprolactone) (PCL) electrospun fibers containing ampicillin sodium salt have been produced and twisted into nanofiber yarns. The fiber diameters and crystallinity, the in vitro antimicrobial properties of the yarns, and the in vitro release of ampicillin from yarns containing various ampicillin concentrations are studied. Decreased fiber diameters and reduced diameter variation are observed with the addition of ampicillin salt into the polymer solution. The results from the zone of inhibition test of the yarns against both gram-positive Staphylococcus aureus and gram-negative Klebsiella pneumoniae indicate that the released ampicillin retains its effectiveness after the production processes, therefore the as-spun yarns are antimicrobial active. A burst release of ampicillin from the yarns has been observed in the first hour, and the release is almost completed in 96 hours. The burst release is believed to be due to the low compatibility of ampicillin with PCL, the accumulation of ampicillin on fiber surface and the small fiber diameters. An empirical release model is developed to describe the release profile. The results indicate that the electrospun nanofibers yarns will have a great potential to be used for biomaterials, such as surgical sutures, to decrease the surgical site infection rate.
References
1.
Inserting and replacing GORE DUALMESH PLUS biomaterial inhibits implant infections by drug-resistant ‘Superbugs” and resists biofilm development, Vol. 2008, Business Wire, 2007.
2.
BideM., Fiber-antibiotic interactions in the development of infection resistant sutures, AATCC Review, 7, No. 9, 2005, 44–48.
3.
MangramA.J., Guideline for prevention of surgical site infection 1999, Infect. Control. Hosp. Epidemiol., 20, 1999, 247–278.
4.
Ethicon: a johnson & johnson company, Ethicon receiveds FDA clearance to market Vicryl* Plus, first ever antibacterial suture, Vol. 2006, 2002.
5.
MaathuisP.G.M., BulstraS.K., in: RakhorstG., and PloegR. J. (Eds.), Biomaterials in modern medicine, World Scientific Publishing Company, New Jersey, 2008, pp. 97–112.
6.
CostertonJ.W., Bacterial biofilms in nature and disease, Annu. Rev. Microbiol., 41, 1987, 435–464.
7.
ElekS.D., ConenP.E., The virulence of S. pyogenes for man. A study of the problems of wound infectionBr. J. Exp. Pathol., 38, 1957, 573–586.
8.
RatnerB.D., Biomaterials Science, 2nd ed., Elsevier Inc., San Diego, 2004.
9.
ChuC.C., Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study, J. Biomed. Mater. Res., 21, No. 11, 1987, 1281–1300.
10.
BlakerJ.J., Development and characterisation of silver doped bioactive glass coated sutures for tissue engineering and wound healing applications, Biomaterials, 25, 2004, 1319–1329.
11.
KovtunE.A., Study of the kinetics of release of decametoxin from modified surgical sutures in aqueous medium, Fibre Chemistry, 31, No. 5, 1999, 374–379.
12.
KovtunE.A., Creation of sutures with antimicrobial properties, Fibre Chemistry, 32, No. 4, 2000, 287–292.
13.
KovtunE.A., PlyganE. P., and SergeevV.P., Study of the stability of modified sutures in biological medium, Fibre Chemistry, 32, No. 6, 2000, 441–443.
14.
SergeevV.P., Development of method of manufacturing modified sutures corresponding to current requirements in medicine, Fibre Chemistry, 34, No. 6, 2002, 433–439.
15.
HuangZ.M., A review on polymer nanofibers by electrospinning and their applications in nanocomposites, Compos. Sci. Technol., 63, No. 15, 2003, 2223–2253.
16.
SillT.J., von RecumH.A., Electro spinning: Applications in drug delivery and tissue engineering, Biomaterials, 29, No. 13, 2008, 1989–2006.
17.
JiaH., Enzyme-carring polymeric nanofibers prepared via electrospinning for use as unique biocatalysts, Biotechnol. Prog., 18, 2002, 1027–1032.
18.
KattiD.S., Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters, J. Biomed. Mater. Res., 70B, 2004, 286–296.
19.
KenawyE.R., Release of tetracycline hydrocloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend, J. Controlled Release, 81, 2002, 57–64.
20.
KimK., Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds, J. Controlled Release, 98, 2004, 47–56.
Luong-VanE., Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers, Biomaterials, 27, No. 9, 2006, 2042–2050.
23.
LuuY.K., Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymer, J. Controlled Release, 89, 2003, 341–353.
24.
VerreckG., Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluable, non-biodegradable polymer, J. Controlled Release, 92, 2003, 349–360.
25.
ZengJ., Biodegradable electrospun fibers for drug delivery, J. Controlled Release, 92, 2003, 227–231.
26.
DingB., Preparation and characterization of a nanoscale poly(vinyl alcohol) fiber aggregate produced by an electrospinning method, J. Polymer. Sci. B Polymer. Phys., 40, 2002, 1261–1268.
27.
FongH., Beaded nanofibers formed during electrospinning, Polymer, 40, 1999, 4548–4592.
28.
HuangL., Engineered collagen-PEO nanofibers and fabrics, J. Biomater. Sci. Polym. Ed., 12, No. 9, 2001, 979–993.
29.
IshiiY., A new electrospinning method to control the number and a diameter of uniaxially aligned polymer fibers, Materials Letters, 62, 2008, 3370–3372.
30.
KattaP., Continuous electrospinning of aligned polymer nanofibers onto a wire drum collector, Nano Lett., 4, No. 11, 2004, 2215–2218.
31.
LeeC.K., The influence of added ionic salt on nanofiber uniformity for electrospinning of electrolyte polymer, Synthetic Metals, 154, 2005, 209–212.
32.
LeeJ.S., Role of molecular weight of atactic poly(vinyl alcohol) (PVA) in the structure and properties of PVA nanofabric prepared by electrospinning, Journal of Applied Polymer Science, 93, 2004, 1638–1646.
33.
RutledgeG.C., FridrikhS.V., Formation of fibers by electrospinning, Advance Drug Delivery Reviews, 59, 2007, 1384–1391.
34.
ThompsonC.J., Effects of parameters on nanofiber diameter determined from electrospinning model, Polymer, 48, 2007, 6913–6922.
35.
YouY., Effect of solution properties on nanofiber structure of electrospun poly(lactic-co-glycolic acid), Journal of Applied Polymer Science, 99, 2006, 1214–1221.
36.
PanH., Continuous aligned polymer fibers produced by a modified electrospinning method, Polymer, 47, 2006, 4901–4904.
37.
CrescenziV., Thermodynamics of fusion of poly-β-propiolactone and poly-∊-caprolactone. Comparative analysis of the melting of aliphatic polylactone and polyester chains, Euro. Polym. J., 8, No. 3, 1972, 449–463.
38.
FuY.M., Differential expression of bla(SHV) related to susceptibility to ampicillin in Klebsiella pneumoniae, Int. J. Antimicrob. Agents, 29, No. 3, 2007, 344–347.
39.
MiyajimaM., Factors influencing the diffusion-controlled release of papaverine from poly(l-lactic acid) matrix, J. Controlled Release, 56, 1998, 85–94.
40.
HuangM.H., Synthesis and degradation of PLA-PCL-PLA triblock copolymer prepared by successive polymerization of epsilon-caprolactone and (DL)-lactide, Polymer, 45, No. 26, 2004, 8675–8681.
41.
LittleU., Accelerated degradation behaviour of poly(epsilon-caprolactone) via melt blending with poly(aspartic acid-co-lactide) (PAL), Polym. Degrad. Stab., 94, No. 2, 2009, 213–220.
42.
Buschle-DillerG., Release of antibiotics from electrospun biocomponent fibers, Cellulose, 14, 2007, 553–562.
43.
ZongX., Structure and process relationship of electrospun bioabsorbable nanofiber membranes, Polymer, 43, 2002, 4403–4412.
44.
FordJ.L., Formulation of sustained release promethazine hydrochloride tablets using hydroxypropylmeethycellulose matrices, Int. J. Pharm., 24, 1985, 327–338.
45.
HsuY.Y., In vitro controlled release of isoniazid from poly(lactide-co-glycolide) matrices, J. Controlled Release, 31, 1994, 223–228.
46.
MiyajimaM., Mechanism of drug release from poly(L-lactic acid) matrix containing acidic or neutral drugs, J. Controlled Release, 60, 1999, 199–209.
47.
RitgerP.L., PeppasN.A., A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, J. Controlled Release, 5, 1987, 23–36.
